January 21st 2024
These data suggest the promise of morphine for cough among those with idiopathic pulmonary fibrosis, though longer term research may be necessary.
Study Finds 3 Monoclonal Antibodies Reduce RSV Infections in High-Risk Infants, Children
February 17th 2023According to the systmatic review, motavizumab, nirsevimab, and palivizumab, are associated with significant reductions in RSV-related infections and hospitalizations without a significant increase in adverse events.